Carib A. Oquendo

Array ( [id] => 5557766 [patent_doc_number] => 20090269343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Dual Specific Immunotoxin for Brain Tumor Therapy' [patent_app_type] => utility [patent_app_number] => 12/418975 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8843 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269343.pdf [firstpage_image] =>[orig_patent_app_number] => 12418975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385673 [patent_doc_number] => 20090226918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Gene overexpressed in cancer' [patent_app_type] => utility [patent_app_number] => 12/384165 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 55225 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226918.pdf [firstpage_image] =>[orig_patent_app_number] => 12384165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195543 [patent_doc_number] => 20110027297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing' [patent_app_type] => utility [patent_app_number] => 12/937178 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23494 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027297.pdf [firstpage_image] =>[orig_patent_app_number] => 12937178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5532946 [patent_doc_number] => 20090232734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/412957 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29488 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232734.pdf [firstpage_image] =>[orig_patent_app_number] => 12412957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174281 [patent_doc_number] => 20110177074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING PDGFRBETA AND VEGF-A' [patent_app_type] => utility [patent_app_number] => 12/934756 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 93312 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177074.pdf [firstpage_image] =>[orig_patent_app_number] => 12934756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479604 [patent_doc_number] => 20090202561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'NOVEL RAAG10 CELL SURFACE TARGET AND A FAMILY OF ANTIBODIES RECOGNIZING THAT TARGET' [patent_app_type] => utility [patent_app_number] => 12/413483 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25877 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202561.pdf [firstpage_image] =>[orig_patent_app_number] => 12413483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569349 [patent_doc_number] => 20090252727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'GLUCAGON RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/405458 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8190 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252727.pdf [firstpage_image] =>[orig_patent_app_number] => 12405458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575849 [patent_doc_number] => 07855275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-21 [patent_title] => 'Cysteine engineered antibodies and conjugates' [patent_app_type] => utility [patent_app_number] => 12/399241 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 33 [patent_no_of_words] => 47043 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855275.pdf [firstpage_image] =>[orig_patent_app_number] => 12399241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403933 [patent_doc_number] => 20090239247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'MN and Hypoxia' [patent_app_type] => utility [patent_app_number] => 12/396879 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 31513 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239247.pdf [firstpage_image] =>[orig_patent_app_number] => 12396879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262156 [patent_doc_number] => 20100297060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/395159 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14086 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297060.pdf [firstpage_image] =>[orig_patent_app_number] => 12395159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342380 [patent_doc_number] => 20090181030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'USE OF A PREPARATION BASED ON AN ANTIBODY DIRECTED AGAINST A TUMOR-ASSOCIATED GLYCOSYLATION' [patent_app_type] => utility [patent_app_number] => 12/391226 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8009 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181030.pdf [firstpage_image] =>[orig_patent_app_number] => 12391226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529339 [patent_doc_number] => 20100221177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'RS7 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/389503 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 24851 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221177.pdf [firstpage_image] =>[orig_patent_app_number] => 12389503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875535 [patent_doc_number] => 08962803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Antibodies against the RGM A protein and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/389927 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 42398 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12389927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495366 [patent_doc_number] => 20090263394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'A34 AND A33-LIKE 3 DNA PROTEIN, ANTIBODIES THERETO AND METHODS OF TREATMENT USING SAME' [patent_app_type] => utility [patent_app_number] => 12/378533 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11402 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263394.pdf [firstpage_image] =>[orig_patent_app_number] => 12378533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574993 [patent_doc_number] => 20090142354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4' [patent_app_type] => utility [patent_app_number] => 12/371159 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15937 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142354.pdf [firstpage_image] =>[orig_patent_app_number] => 12371159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9523588 [patent_doc_number] => 08747847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Monoclonal antibodies for tumor treatment' [patent_app_type] => utility [patent_app_number] => 12/867208 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 31 [patent_no_of_words] => 16710 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316445 [patent_doc_number] => 20090281043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'TUMOR ANTIGEN BASED ON PRODUCTS OF THE TUMOR SUPPRESSOR GENE WT1' [patent_app_type] => utility [patent_app_number] => 12/366200 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 4934 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281043.pdf [firstpage_image] =>[orig_patent_app_number] => 12366200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146277 [patent_doc_number] => 08163280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Antibodies to c-Met' [patent_app_type] => utility [patent_app_number] => 12/321963 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 37374 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163280.pdf [firstpage_image] =>[orig_patent_app_number] => 12321963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343241 [patent_doc_number] => 20090181891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 213P1F11 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/357253 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 69472 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181891.pdf [firstpage_image] =>[orig_patent_app_number] => 12357253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574295 [patent_doc_number] => 07829675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'TWEAK receptor' [patent_app_type] => utility [patent_app_number] => 12/355733 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21027 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829675.pdf [firstpage_image] =>[orig_patent_app_number] => 12355733 [rel_patent_id] =>[rel_patent_doc_number] =>)